Business Context and Reporting Period
Company: Ocular Therapeutix, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 7, 2018
Reporting Period: Quarter ended September 30, 2018
Status: Emerging Growth Company
This filing serves to announce the Company's financial results for the quarter ended September 30, 2018. The detailed results are contained in a press release furnished as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only indicates that financial results for the quarter were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the full announcement of results but does not include the commentary itself.
Legal Disclaimer: The information in this Current Report, including the press release, is furnished to comply with Item 2.02 of Form 8-K. It is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 7, 2018) for specific revenue, net loss, and cash position figures.
- Verify the Company's status as an Emerging Growth Company and its election regarding the extended transition period for new accounting standards.
- Confirm the specific details of the financial results and any forward-looking statements contained in the referenced press release.